title: Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?
abstract: Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A 78-year-old lady was admitted for elective coronary artery bypass graft surgery. On the second day of admission, she developed acute left hemiparesis and intravenous rTPA was administered within 120 minutes. Three hours later, she has had chest pain. Rescue percutaneous coronary intervention was performed on right coronary artery due to diagnosis of inferior MI, and the symptoms were resolved.
authors.affiliation: Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Mostafa
authors.initials: M
authors.lastname: Almasi
authors.affiliation: Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Saeed
authors.initials: S
authors.lastname: Razmeh
authors.affiliation: Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Amir Hassan
authors.initials: AH
authors.lastname: Habibi
authors.affiliation: Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences , Tehran, Iran.
authors.forename: Amir Hassan
authors.initials: AH
authors.lastname: Rezaee
keywords: Acute ischemic stroke; Myocardial infarction; Recombinant tissue plasminogen activator